Halofenate: an effective hypolipemia- and hypouricemia-inducing drug.
D000328:Adult; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000097:blood / Q000188:drug therapy; D003864:Depression, Chemical; D005260:Female; D006016:Glycolates / Q000627:therapeutic use*; D006218:Halofenate / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D013997:Time Factors; D014280:Triglycerides / Q000097:blood; D014527:Uric Acid / Q000037:antagonists & inhibitors* / Q000097:blood
D006016:Glycolates; D000960:Hypolipidemic Agents; D014280:Triglycerides; D014527:Uric Acid; D006218:Halofenate